|
|
Article: Dr. Shimon Slavin Joins Cancer Treatment Centers of America as Medical Director of Immunotherapy.
- Article from:
- PR Newswire
- Article date:
- August 2, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Internationally Renowned Specialist in Transplant Therapies to Initiate New
Protocols for Bone Marrow Transplant at Cancer Treatment Centers of America
ARLINGTON HEIGHTS, Ill, Aug. 2 /PRNewswire/ --
Shimon Slavin, MD, Director of Israel's National Bone Marrow Transplant Center, has been named Medical Director of Immunotherapy to initiate new protocols for bone marrow transplant at Cancer Treatment Centers of America (CTCA) and its five cancer centers.
Dr. Slavin is a leading medical oncologist in the field of allogeneic bone marrow transplantation and immunology used in the treatment of hematologic and solid tumor cancer. His current ...